The U.S. Food and Drug Administration on Friday approved Biogen and Sage Therapeutics' oral pill for two common forms of depression, paving the way for patients to get a faster-acting therapy to treat their mood disorders.

(Reporting by Sriparna Roy and Lavanya Ahire in Bengaluru; Editing by Krishna Chandra Eluri and Leslie Adler)